查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
细胞和基因疗法市场：按治疗类型、按应用、按最终用户、按地区：规模、份额、前景、机会分析，2023-2030 年
市场调查报告书
商品编码
1349969

细胞和基因疗法市场：按治疗类型、按应用、按最终用户、按地区：规模、份额、前景、机会分析，2023-2030 年

Cell and Gene Therapy Market, By Therapy Type, By Application, By End User, By Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
出版日期: | 出版商: Coherent Market Insights | 英文 247 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计到 2023 年，全球细胞和基因治疗市场将达到 227 亿美元，预测期内（2023-2030 年）复合年增长率为 28.7%。

报告范围 报告详情
基准年 2022年 2023年市场规模 美国：227亿美元
之前的数据 2018年至2021年 预测期 2023-2030
预测 2023-2030 年复合年增长率： 28.70% 2030年价值预测 美国：1326亿美元
细胞和基因治疗市场-IMG1

细胞疗法是将新细胞引入患者体内，使其生长、替换和修復受损组织，进而治疗疾病。细胞疗法可以使用许多不同类型的细胞，包括干细胞、淋巴细胞和树突状细胞。细胞疗法使用取自患者自身的细胞（自体细胞）和取自捐赠者的细胞（同种异体细胞）。许多细胞疗法使用经过基因重新编程的成体细胞，这些细胞可以成为患者体内多种类型细胞中的任何一种。这项技术有潜力开发出无限数量的治疗目的所需的特定人类细胞。

基因疗法试图修改或将基因引入患者体内以治疗、预防或潜在治癒疾病。基因治疗方法的例子包括以功能性拷贝取代致病突变基因，或将新的、正确的基因拷贝引入体内。

市场动态

细胞和基因疗法在现代医疗保健中发挥着重要作用，因为它提供了可用于基因调控、细胞间相互作用、再生能力和重塑的概念和技术。因此，主要市场参与者正专注于实施各种成长策略，例如产品/平台发布，预计将在预测期内推动市场成长。例如，2023 年 4 月 4 日，全球医疗保健公司 AmerisourceBergen 宣布推出细胞与基因治疗 (CGT) 整合中心。该系统可以与生物製药和提供者的平台集成，以促进即时数据交换，并协助整个患者旅程中的治疗开发和服务编排。

本研究的主要特点

  • 该报告对全球细胞和基因治疗市场进行了详细分析，并提出了以2022年为基准年的预测期（2023-2030）的市场规模和复合年增长率（CAGR）。
  • 它还揭示了各个细分市场的潜在收入机会，并为该市场提供了一系列有吸引力的投资建议。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和批准、市场趋势、区域前景、主要参与者采取的竞争策略等的重要见解。
  • 根据公司亮点、产品组合、主要亮点、财务表现和策略等参数对全球细胞和基因治疗市场的主要参与者进行了分析。
  • 本研究涵盖的主要公司包括Novartis International AG, Pfizer, Inc., Sanofi S.A., Amgen, Inc., Regeneron Pharmaceuticals, Inc., Bluebird Bio, Inc.（Celgene Corporation）, Biogen Inc., uniQure N.V., JCR Pharmaceuticals Co. Ltd., Gene Biotherapeutics, Kolon TissueGene, Inc., Horama S.A., MeiraGTx Limited, Gilead Sciences, Inc., Organogenesis, Inc., Orchard Therapeutics Plc., Freeline Therapeutics Ltd. , Bristol-Myers Squibb Company, PTC Therapeutics, Inc., Spark Therapeutics, Inc. and Biomarin Pharmaceutical Inc.
  • 该报告的见解使行销人员和公司高管能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
  • 全球细胞和基因治疗市场报告迎合了该行业的各种利益相关者，如投资者、供应商、产品製造商、分销商、新进业者和财务分析师。
  • 利害关係人可以透过用于分析全球细胞和基因治疗市场的各种策略矩阵来促进他们的决策。

目录

第一章 研究目的与前提

  • 研究目标
  • 先决条件
  • 缩略语

第二章 市场概况

  • 报告摘要
    • 市场定义和范围
  • 执行摘要
  • 连贯的机会地图 (COM)

第三章 市场动态、法规与趋势分析

  • 市场动态
    • 促进者
    • 抑製剂
    • 市场机会
  • 影响分析
  • 合併、收购、联盟
  • 监管场景
  • 重大发展
  • PEST分析
  • 技术进步
  • 製造商收入
  • 管道分析

第 4 章 全球细胞与基因治疗市场 - COVID-19 影响分析

  • 经济影响
  • COVID-19 流行病学
  • 对供需的影响

第五章全球细胞与基因治疗市场：依治疗类型，2018-2030

  • 细胞疗法
  • 干细胞
  • T细胞
  • 树突状细胞
  • 自然杀手细胞
  • 基因治疗
  • 生殖细胞基因治疗
  • 体细胞基因治疗

第六章 全球细胞与基因治疗市场：依应用分类，2018-2030

  • 皮肤科
  • 肌肉骨骼系统
  • 肿瘤学
  • 免疫学
  • 心臟病学/神经病学
  • 其他（泌尿系统疾病、传染病、眼科疾病、视网膜疾病等）

第 7 章 全球细胞与基因治疗市场：依最终使用者划分，2018-2030 年

  • 医院
  • 诊所
  • 其他（研究机构、学术机构等）

第 8 章 全球细胞与基因治疗市场：按地区划分，2018-2030 年

  • 北美
  • 美国
  • 加拿大
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 欧洲
  • 英国
  • 德国
  • 意大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 欧洲其他地区
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 东盟
  • 澳大利亚
  • 韩国
  • 亚太其他地区
  • 中东
  • 海湾合作委员会
  • 以色列
  • 其他中东
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第9章 竞争格局

  • Novartis International AG
  • Pfizer, Inc.
  • Sanofi S.A.
  • Amgen, Inc.
  • Regeneron Pharmaceuticals, Inc.
  • Bluebird Bio, Inc.（Celgene Corporation）
  • Biogen Inc.
  • uniQure N.V.
  • JCR Pharmaceuticals Co. Ltd.
  • Gene Biotherapeutics
  • Kolon TissueGene, Inc.
  • Horama S.A.
  • MeiraGTx Limited
  • Gilead Sciences, Inc.
  • Organogenesis, Inc.
  • Orchard Therapeutics Plc.
  • Freeline Therapeutics Ltd.
  • Bristol-Myers Squibb Company
  • PTC Therapeutics, Inc.
  • Spark Therapeutics, Inc.
  • Biomarin Pharmaceutical Inc.

第10章

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI2475

The global cell and gene therapy market is estimated to be valued at US$ 22.7 billion in 2023 and is expected to exhibit a CAGR of 28.7% during the forecast period (2023-2030).

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 22.7 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 28.70% 2030 Value Projection: US$ 132.6 Bn
Cell and Gene Therapy Market - IMG1

Cell therapy is the introduction of new cells into a patient's body to grow, replace, or repair damaged tissue in order to treat a disease. A variety of different types of cells can be used in cell therapy, including stem cells, lymphocytes, and dendritic cells. Cell therapies can use cells from the patient's own body (autologous) or from a donor (allogenic). Many cell therapies use adult cells that have been genetically reprogrammed and capable of becoming one of many types of cells inside a patient's body. This technology may enable the development of unlimited types of specific human cells needed for therapeutic purposes.

Gene therapy seeks to modify or introduce genes into a patient's body with the goal of treating, preventing, or potentially curing a disease. Examples of gene therapy approaches include replacing a mutated gene that causes disease with a functional copy or introducing a new, correct copy of a gene into the body.

Market Dynamics

Cell and gene therapy plays a major role in modern healthcare, as it provides concepts and techniques that can be used in gene regulation, cell-cell interactions, regenerative capacity, and remodeling. Thus, key market players are focused on adopting various growth strategies such as product/platform launches and others, which in turn is expected to fuel the market growth over the forecast period. For instance, on April 4, 2023, AmerisourceBergen, a global healthcare company, announced the launch of its Cell and Gene Therapy (CGT) Integration Hub, a system that can be integrated with biopharma or provider-facing platforms to facilitate real-time data exchange and help orchestrate services across the treatment development and patient journey.

Furthermore, The CGT Integration Hub, which is platform-agnostic and powered by AmerisourceBergen's innovative customer relationship management (CRM) system, aims to streamline the path-to-care process, in part, by providing physicians and patient services teams with enhanced visibility across the therapy development and delivery process. Through platform integrations, the CGT Integration Hub can:

  • Speed up the benefits investigation process so that after physicians enter patient enrollment data, they can get a decision on the patient's coverage almost immediately.
  • To facilitate patient scheduling, give doctors and care managers real-time access to information on the status of the development of the therapy and transportation.
  • Inform case managers of any status changes, such as postponed arrival dates, so they can contact patients and caregivers in advance to amend any scheduled treatment-related activities or stays, as necessary.

Key features of the study:

  • This report provides an in-depth analysis of the global cell and gene therapy market and provides market size (US$ Billion) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global cell and gene therapy market based on the following parameters-Company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Novartis International AG, Pfizer, Inc., Sanofi S.A., Amgen, Inc., Regeneron Pharmaceuticals, Inc., Bluebird Bio, Inc. (Celgene Corporation) , Biogen Inc., uniQure N.V., JCR Pharmaceuticals Co. Ltd., Gene Biotherapeutics, Kolon TissueGene, Inc., Horama S.A., MeiraGTx Limited, Gilead Sciences, Inc., Organogenesis, Inc., Orchard Therapeutics Plc., Freeline Therapeutics Ltd. , Bristol-Myers Squibb Company, PTC Therapeutics, Inc., Spark Therapeutics, Inc. and Biomarin Pharmaceutical Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global cell and gene therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell and gene therapy market

Detailed Segmentation:

  • Global Cell and Gene Therapy Market, By Therapy Type:
    • Cell Therapy
    • Stem Cells
    • T Cells
    • Dendritic Cells
    • NK Cells
    • Gene Therapy
    • Germline Gene Therapy
    • Somatic Gene Therapy
  • Global Cell and Gene Therapy Market, By Application:
    • Dermatology
    • Musculoskeletal
    • Oncology
    • Immunology
    • Cardiology & Neurology
    • Others (Urinary Problems, Infectious Disease, Ophthalmic, Diseases, Retinal Diseases, And Others)
  • Global Cell and Gene Therapy Market, By End user:
    • Hospitals
    • Clinics
    • Others (Research Institutes, Academic Institutes, etc.)
  • Global Cell and Gene Therapy Market, By Region:
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
    • Novartis International AG
    • Pfizer, Inc.
    • Sanofi S.A.
    • Amgen, Inc.
    • Regeneron Pharmaceuticals, Inc.
    • Bluebird Bio, Inc. (Celgene Corporation)
    • Biogen Inc.
    • uniQure N.V.
    • JCR Pharmaceuticals Co. Ltd.
    • Gene Biotherapeutics
    • Kolon TissueGene, Inc.
    • Horama S.A.
    • MeiraGTx Limited
    • Gilead Sciences, Inc.
    • Organogenesis, Inc.
    • Orchard Therapeutics Plc.
    • Freeline Therapeutics Ltd.
    • Bristol-Myers Squibb Company
    • PTC Therapeutics, Inc.
    • Spark Therapeutics, Inc.
    • Biomarin Pharmaceutical Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Therapy Type
    • Market Snapshot, By Application
    • Market Snapshot, By End user
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Merger, Acquisition, and Collaborations
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis
  • Technological Advancements
  • Manufacturer Revenue
  • Pipeline Analysis

4. Global Cell and Gene Therapy Market - COVID-19 Impact Analysis

  • Economic Impact
  • COVID-19 Epidemiology
  • Impact on Supply and Demand

5. Global Cell and Gene Therapy Market, By Therapy Type, 2018 - 2030, (US$ Billion)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Cell Therapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Billion)
    • Segment Trends
  • Stem Cells
  • T Cells
  • Dendritic Cells
  • NK Cells
  • Gene Therapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Billion)
    • Segment Trends
  • Germline Gene Therapy
  • Somatic Gene Therapy

6. Global Cell and Gene Therapy Market, By Application, 2018 - 2030, (US$ Billion)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Dermatology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Billion)
    • Segment Trends
  • Musculoskeletal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Billion)
    • Segment Trends
  • Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Billion)
    • Segment Trends
  • Immunology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Billion)
    • Segment Trends
  • Cardiology & Neurology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Billion)
    • Segment Trends
  • Others (Urinary Problems, Infectious Disease, Ophthalmic, Diseases, Retinal Diseases, And Others)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Billion)
    • Segment Trends

7. Global Cell and Gene Therapy Market, By End user, 2018 - 2030, (US$ Billion)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Billion)
  • Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Billion)
  • Others (Research Institutes, Academic Institutes, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Billion)

8. Global Cell and Gene Therapy Market, By Region, 2018 - 2030, (US$ Billion)

  • Introduction
    • Market Share Analysis, By Region, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Regions, 2018-2030
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End user, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country , 2018 - 2030, (US$ Billion)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End user, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country , 2018 - 2030, (US$ Billion)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End user, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country , 2018 - 2030, (US$ Billion)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End user, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country , 2018 - 2030, (US$ Billion)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End user, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country , 2018 - 2030, (US$ Billion)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End user, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country , 2018 - 2030, (US$ Billion)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

  • Novartis International AG*
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Pfizer, Inc.
  • Sanofi S.A.
  • Amgen, Inc.
  • Regeneron Pharmaceuticals, Inc.
  • Bluebird Bio, Inc. (Celgene Corporation)
  • Biogen Inc.
  • uniQure N.V.
  • JCR Pharmaceuticals Co. Ltd.
  • Gene Biotherapeutics
  • Kolon TissueGene, Inc.
  • Horama S.A.
  • MeiraGTx Limited
  • Gilead Sciences, Inc.
  • Organogenesis, Inc.
  • Orchard Therapeutics Plc.
  • Freeline Therapeutics Ltd.
  • Bristol-Myers Squibb Company
  • PTC Therapeutics, Inc.
  • Spark Therapeutics, Inc.
  • Biomarin Pharmaceutical Inc.

10. Section

  • Research Methodology
  • About Us